Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis
Status:
Terminated
Trial end date:
2018-05-10
Target enrollment:
Participant gender:
Summary
In this research study, the investigators will determine whether a procedure called
Extracorporeal Photopheresis (ECP) is helpful in preventing progression of disability in
people with SPMS when compared to monthly corticosteroid infusions. This study will determine
whether ECP has an effect on inflammatory cells in people with SPMS and whether it has a
beneficial therapeutic effect.